Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.

about

Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.

Item

http://www.wikidata.org/entity/Q55518172

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Therapies based on targeting E ...... r EBV-associated malignancies.

@en

Therapies based on targeting E ...... r EBV-associated malignancies.

@nl

type

Item

label

Therapies based on targeting E ...... r EBV-associated malignancies.

@en

Therapies based on targeting E ...... r EBV-associated malignancies.

@nl

prefLabel

Therapies based on targeting E ...... r EBV-associated malignancies.

@en

Therapies based on targeting E ...... r EBV-associated malignancies.

@nl

P1476

Therapies based on targeting E ...... or EBV-associated malignancies

@en

P2093

Ann M Bode

http://www.w3.org/2001/XMLSchema#string

Jianmin Hu

http://www.w3.org/2001/XMLSchema#string

Xiangjian Luo

http://www.w3.org/2001/XMLSchema#string

Ya Cao

http://www.w3.org/2001/XMLSchema#string

Zigang Dong

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells

Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies

Epstein-Barr virus: 40 years on

Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor.

Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo

Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.

Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation

Gap junctions.

Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.

P304

2101-2108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13634

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Hongde Li

P5008

ScienceSource

P577

2018-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29751367

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

Herpesviridae infectious disease

Epstein–Barr virus infection

Epstein–Barr virus

tumor virus infections

P932

6029825

http://www.w3.org/2001/XMLSchema#string